=Transenterix (TRXC) issues upside guidance for Q2

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 119
HQ:  Morrisville, North Carolina
http://www.transenterix.com
Earnings Aug 07 AMC


Transenterix sees Q2 revs above consensus 

• Co issues upside guidance for Q2 (Jun), sees Q2 (Jun) revs of $6.0-6.3 mln vs. $5.44 mln Capital IQ Consensus Estimate.
• On June 7, 2018, the Company announced that it had filed an FDA 510k submission for additional Senhance System instruments, including 3 millimeter diameter instruments.